Revisiting oral fluoropyrimidine with cetuximab in metastatic colorectal cancer: Real-world data in Chinese population

BACKGROUND: Cetuximab in combination with oral fluoropyrimidine (FP) remains controversial in metastatic colorectal cancer (mCRC). In view of the regional variation in the tolerability of FP, we conducted a retrospective analysis to compare oral FP with infusional FP in combination with cetuximab in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Ka-On, Fu, Man-Chi, Lau, Kin-Sang, Lam, Kam-Mo, Choi, Cheuk-Wai, Chiu, Wan-Hang, Yuen, Cheng-Man, Kwok, Lai-Han, Tam, Fong-Kit, Chan, Wing-Lok, Chan, Sum-Yin, Ho, Pui-Ying, Leung, To-Wai, Lee, Ho-Fun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883182/
https://www.ncbi.nlm.nih.gov/pubmed/31798783
http://dx.doi.org/10.4251/wjgo.v11.i11.1031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883182/
https://www.ncbi.nlm.nih.gov/pubmed/31798783
http://dx.doi.org/10.4251/wjgo.v11.i11.1031

Ejemplares similares